We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets closed
All Screeners/


Default Criteria
Matching Options1-18 of 18 results
Add to Portfolio
Results were generated a few mins ago. Pricing data is updated frequently. Currency in USD
Underlying SymbolNameStrikeExpiration DatePrice (Intraday)Change% ChangeBidAskVolumeOpen Interest
KODKOD Dec 2023 0.500 call0.502023-12-141.65000.00000.00%0.001.8011
KRONKRON Nov 2023 5.000 call5.002023-11-160.10000.00000.00%0.002.60112
FGENFGEN Oct 2023 1.000 call1.002023-10-050.1000+0.0500+100.00%0.001.60113
TLRYTLRY Oct 2023 0.500 call0.502023-10-121.83000.00000.00%0.764.0027
PHUNPHUN Oct 2023 0.500 put0.502023-10-050.30000.00000.00%0.050.45N/A1
RDWRDW Oct 2023 2.500 call2.502023-10-050.69000.00000.00%0.004.8011
IDEXIDEX Oct 2023 0.500 put0.502023-10-190.45000.00000.00%0.450.5048119
EBETEBET Oct 2023 5.000 call5.002023-10-190.01000.00000.00%0.000.051140
TALTAL Oct 2023 1.500 call1.502023-10-057.310.000.00%7.059.6522
EBETEBET Oct 2023 2.500 call2.502023-10-190.0100-0.0400-80.00%0.000.0521814
SNDLSNDL Nov 2023 1.000 call1.002023-11-021.10000.00000.00%0.723.001515
PSNYPSNY Oct 2023 1.000 call1.002023-10-121.25000.00000.00%1.273.7511
WEWE Oct 2023 1.000 put(CONTRACT_1.002023-10-190.90000.00000.00%0.851.0046
APAP Oct 2023 2.500 put2.502023-10-190.1000-0.4500-81.82%0.000.65125
SDCSDC Jan 2024 0.500 call0.502024-01-180.1500-0.0100-6.25%0.140.1726,532
DCFCDCFC Nov 2023 3.000 call3.002023-11-160.6500+0.6000+1,200.00%0.000.603352
TGTXTGTX Oct 2023 2.000 call2.002023-10-056.750.000.00%6.008.6011
UCARUCAR Oct 2023 3.500 call3.502023-10-050.65000.00000.00%0.105.00N/A38
Show 25 rows
  • Motley Fool

    2 Growth Stocks I'd Buy on the Dip

    For my money, I like both Acadia Pharmaceuticals (NASDAQ: ACAD) and Tilray Brands (NASDAQ: TLRY) at current levels. In August, Tilray Brands struck a tremendous asset deal with Anheuser-Busch to acquire eight beer and beverage brands.

  • Bloomberg

    SmileDirectClub Files for Bankruptcy, Capping Years of Losses

    (Bloomberg) -- Dental aligner company SmileDirectClub Inc. filed for bankruptcy four years after raising $1.35 billion in an initial public offering. Most Read from BloombergOnce Unthinkable Bond Yields Now the New Normal For MarketsCongress Averts US Government Shutdown Hours Before DeadlineSenate Voting on Bill to Avert US Government ShutdownMcCarthy to Face Far-Right Attempt to Oust Him as House SpeakerMarket Stress Rises Over Wild Week Ahead Even Without a ShutdownThe Chapter 11 filing in Te

  • GlobeNewswire

    SmileDirectClub Seeks to Execute Comprehensive Recapitalization to Strengthen the Business for Sustainable Growth

    Company Intends to Maintain Normal Operations, Transforming Smiles Without DisruptionNASHVILLE, Tenn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care Company with the first medtech platform for teeth straightening, today announced a process to implement a comprehensive recapitalization transaction. The additional capital and stronger financial position from this recapitalization is intended to bolster the Company’s balance sheet and fuel gro

  • Yahoo Finance

    Yahoo Finance exclusive: SmileDirectClub files for Chapter 11 bankruptcy, eyes restructuring

    SmileDirectClub buckles under the weight of several obstacles.


    EBET Announces Reverse Stock Split

    LAS VEGAS, NV / ACCESSWIRE / September 29, 2023 / EBET, Inc., (NASDAQ:EBET) a leading global provider of advanced wagering products and technology, announced, today announced that it filed an amendment to articles of incorporation with the Secretary ...

  • GlobeNewswire

    ‘Potently Canadian' Cannabis Brand, CANACA, Launches ‘Let ‘Er Rip’ Campaign

    CANACA Introduces New Flower Offerings and Infused Pre-roll LineupTORONTO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced the launch of its expanded product lineup by its quintessentially Canadian cannabis lifestyle brand, CANACA. Introducing its new ‘Let ‘Er Rip’ Campaign, a curated collection of products crafted to elevate intensity while offering flavou

  • PR Newswire

    SNDL and Nova Cannabis Extend Outside Date for Closing of the Strategic Partnership

    SNDL Inc. (NASDAQ: SNDL) ("SNDL") and Nova Cannabis Inc. (TSX: NOVC) ("Nova") announced today that while all other provincial approvals have been received, the continued review by one provincial regulator has necessitated a further extension of the outside date for the closing of the previously-announced strategic partnership (the "Transaction"). SNDL and Nova anticipate that the Transaction will close on or before October 30, 2023, subject to receipt of regulatory approval.

  • PR Newswire

    TAL Education Group to Announce Second Quarter of Fiscal Year 2024 Financial Results on October 26, 2023

    TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the second quarter of fiscal year 2024 ended August 31, 2023, before the market opens on Thursday, October 26, 2023.

  • Yahoo Finance Video

    Cannabis legislation: SAFER Banking Act advances in the Senate

    Cannabis legislation might be nearing a milestone. If passed through Congress, the SAFER Banking Act could give registered cannabis businesses access to small business loans and various financial protections. Poseidon (PSDN) Co-Founder and Managing Partner Emily Paxhia joins Yahoo Finance Live and notes that this is the first time the SAFER Banking Act has made a run through the Senate, but expresses concerns that it “might not be a priority” for House lawmakers amid the approaching 2024 election and the looming threat of a government shutdown. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

  • Investor's Business Daily

    Is TLRY Stock A Buy As We Wait For Cannabis To Be Rescheduled?

    Canadian cannabis producer Tilray is expanding its product base and improving its bottom line. With new acquisitions and the stock off its 52-week low, is TLRY stock a bargain buy now? Schedule 1 drugs include heroin and LSD and are said to have "no currently accepted medical use and a high potential for abuse," as defined by the U.S. Drug Enforcement Administration.